Home › Alpha-1 Antitrypsin Deficiency › Colorado
Alpha-1 Antitrypsin Deficiency clinical trials in Colorado
3 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in Colorado.
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- Peak Gastroenterology Associates, Colorado Springs
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Nov 12, 2026 · NCT06165341Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Peak Gastroenterology Associates, PC, Colorado Springs
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated May 13, 2026 · NCT05677971PiMZ Longitudinal Cohort (PiMZ Logic)
- National Jewish Health, Denver
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT06505603From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.